Formation and Detection of Fibrinogen Derived Complexes^[*]

 

^* Presented at the Postgraduate Course and Workshop “Progress in Fibrinolysis”, Milano, Italy, March 6–8, 1975.

• References

• 1 Alkjaersig N, Roy L, and Fletcher A. P. 1973; Analysis of gel exclusion chromatographic data by chromatographic plate theory analysis : Application to plasma fibrinogen chromatography. Thrombosis Research 3: 525.
• 2 Bang N. U, Hansen M. S, Smith G. F, Latallo Z. S, Chang M. L, and Mattler L. E. 1973; Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states. Series Haematologica 4: 494.
• 3 Donelly T. H, Lasowski Jr. M, Notley N, and Scheraga H. A. 1955; Equilibria in the fibrinogen-fibrin conversion, II. Reversibility of the polymerization steps. Archives Biochemica Biophysica 56: 369.
• 4 Fletcher A. P, and Alkjaersig N. 1971; Blood hypercoagulability, intravascular coagulation and thrombosis: new diagnostic concepts. Thrombosis Diathesis Haemorrhagica Suppl. 45: 389.
• 5 Godal H. C, and Abildgaard U. 1966; Gelation of soluble fibrin in plasma by ethanol. Scandinavian Journal of Haematology 3: 342.
• 6 Graeff H, von Huge R, and Hafter R. 1973; In vivo formation of soluble fibrin monomer complexes in human plasma. Thrombosis Research 3: 465.
• 7 Gurewich V, Lipinski B, and Lipinska I. 1973; A comparative study of precipitation and paracoagulation by protamine sulfate and ethanol gelation tests. Thrombosis Research 2: 539.
• 8 Heene D. L, and Matthias F. R. 1973; Absorption of fibrinogen derivatives on insolubilized fibrinogen and fibrin monomer. Thrombosis Research 2: 137.
• 9 Heene D. L, Matthias F. R, Wegrzynowicz Z, and Hocke G. 1975 Separation of fibrinogen degradation products (FDP) by means of absorption to fibrin monomer (FM-ag). Presented at the Twenty-third annual Symposium on Blood. The Fibrinolytic system: Physiologic and Molecular Aspects. Detroit, Michigan U.S.A. 23-24 January 1975.
• 10 Hedner U, and Nilsson I. M. 1972; Parallel determinations of FDP and fibrin monomers with various methods. Thrombosis Diathesis Haemorrhagica (Stuttg.) 28: 268.
• 11 Jacobsen C. D, and Southers N. J. 1973; Ethanol gelation and protamine sulphate tests: Comparison and critique. Thrombosis Diathesis Haemorrhagica 29: 130.
• 12 Kidder W. R, Logan L. J, Rapaport S. I, and Patch M. J. 1972; The plasma protamine paracoagulation test: clinical and laboratory evaluation. American Journal of Clinical pathology 58: 675.
• 13 Kierulf P, and Abildgaard W. 1971; Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma. Scandinavian Journal of Clinical and Laboratory Investigation 28: 231.
• 14 Kierulf P, and Godal H. C. 1971; Fibrinemia in medical patients screened by the ethanol test. Acta Medica Scandinavica 190: 185.
• 15 Kisker C. T, and Rush R. 1971; Detection of intravascular coagulation. Journal of Clinical Investigation 50: 2235.
• 16 Kloczewiak M, Zajdel M, and Latallo Z. S. 1974 Unpublished observations.
• 17 Kottinen Y. P, Kemppainen L, and Turnen O. 1972; Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation. Thrombosis Diathesis Haemorrhagica (Stuttg.) 28: 342.
• 18 Kopec M, Wegrzynowicz Z, and Latallo Z. S. 1970; Soluble fibrin complexes and a new specific test for their detection. Thrombosis Diathesis Haemorrhagica (Stuttg.) Suppl. 39: 219.
• 19 Kopec M, Wegrzynowicz Z, Kloczewiak M, and Latallo Z. S. 1972; Antithrombin action of fibrinogen degradation products (FDP). Folia Haematologica, Leipzig 98: 417.
• 20 Kowalski E. 1968; Fibrinogen derivatives and their biologic activities. Seminars in Haematology 5: 45.
• 21 Kudryk B, Reuterby J, and Blombäck B. 1973; Adsorption of plasmic fragment D to thrombin modified fibrinogen-sepharose. Thrombosis Research 2: 297.
• 22 Larrieu M. J, Marder V. J, and Inceman S. 1966; Effects of fibrinogen degradation products in platelets and coagulation. Thrombosis Diathesis Haemorrhagica Suppl. 20: 215.
• 23 Latallo Z. S, Fletcher A. P, Alkjaersig N, and Sherry S. 1962; Inhibition of fibrin polymerization by fibrinogen proteolysis products. American Journal of Physiology 202: 681.
• 24 Latallo Z. S, Budzynski A. Z, Lipinski B, and Kowalski E. 1964; Inhibition of thrombin and fibrin polymerization, two activities derived from plasmin-digested fibrinogen. Nature 203: 1184.
• 25 Latallo Z. S, Wegrzynowicz Z, Budzynski A. Z, and Kopec M. 1971; Effect of protamine sulphate on the solubility of fibrinogen, its derivatives and other plasma proteins. Scandinavian Journal of Haematology Suppl. 13: 151.
• 26 Latallo Z. S, Wegrzynowicz Z, Teisseyre E, and Kopec M. 1971; a Simple and rapid evaluation of the intravascular coagulation and fibrinolytic states by application of protamine sulphate and reptilase R. Scandinavian Journal of Haematology Suppl. 13: 387.
• 27 Lipinski B, Budzynski A. Z, Latallo Z. S, and Kowalski E. 1964; Isolation and characterisation of cold-insoluble fibrinogen complexes from bovine plasma. Acta Biochimica Polonica 9: 527.
• 28 Lipinski B, and Worowski K. 1968; Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test. Thrombosis Diathesis Haemorrhagica (Stuttg.) 20: 44.
• 29 Ly B, Kierulf P, and Jakobsen E. 1974; Stabilization of soluble fibrinogen-fibrin complexes by fibrin-stabilizing factor. Thrombosis Research 4: 509.
• 30 Marder V. J, and Shulman N. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin, II. Mechanism of their anticoagulant activity. Journal of Biological Chemistry 244: 2120.
• 31 Niewiarowski S, and Gurewich V. 1971; Laboratory identification of intravascular coagulation : The SDPS test for the detection of fibrin monomer and fibrin degradation products. Journal of Laboratory and Clinical Medicine 77: 665.
• 32 Palester-Chlebowczyk M, Strzyzewska E, Sitkowski W, Ölender A, Wegrzynowicz Z, and Latallo Z. S. 1971; Preliminary results of the protamine sulphate test in plasma of various patients. Scandinavian Journal of Haematology Suppl. 13: 183.
• 33 Sasaki T, Page I. H, and Shainoff J. R. 1966; Stable complexes of fibrinogen and fibrin. Science 152: 1069.
• 34 Scheraga H. A. 1961. Protein structure. Academic Press; N.Y., London:
• 35 Seaman A. J. 1970; The recognition of intravascular clotting. The plasma protamine paracoagulation test. Archives of Internal Medicine 125: 1016.
• 36 Shainoff J. B, and Page I. H. 1960; Cofibrin and fibrin intermediates as indicator of thrombin activity in vivo. Circulation Research 8: 1013.
• 37 Shainoff J. R, and Page I. H. 1962; Significance of cryoprofibrin in fibrinogen-fibrin conversion. Journal of Experimental Medicine 116: 687.
• 38 Smith G. F, and Bang N. U. 1972; Formation of soluble fibrin polymers. Fibrin degradation fragments D and D fail to form soluble complexes with fibrin monomer. Biochemistry 11: 2958.
• 39 Wegrzynowicz Z, Kopec M, and Latallo Z. S. 1971; Formation of soluble fibrin complexes and some factors affecting their solubility. Scandinavian Journal of Haematology Suppl. 13: 49.
• 40 Wegrzynowicz Z, Kloczewiak M, and Kopec M. 1975 Tritiated bovine fibrinogen labelled on fìbrinopeptide A region. Journal of Laboratory and Clinical Medicine (in press).